Abstract |
This study investigated the therapeutic efficacy of two different beta-blockers, metoprolol (beta 1-selective) and nipradilol (nonselective) for the treatment of idiopathic dilated cardiomyopathy (DCM). The New York Heart Association functional class improved in the metoprolol group (n = 9) and the nipradilol group (n = 9), but not in the control group who received conventional therapy (n = 8). The left ventricular ejection fraction increased in both the beta-blocker groups (p < 0.01, p < 0.05). Lymphocyte beta- adrenoceptors were upregulated in the nipradilol group (p < 0.01). Cardiac events were less common in both the beta-blocker groups than in the control group (both p < 0.05). Thus, nipradilol improved symptoms and cardiac function with a favorable effect on sympathoneuronal activity as well as metoprolol in patients with DCM. Therefore, beta 1-selectivity is not essential to achieve therapeutic efficacy with beta-blockade therapy for DCM.
|
Authors | T Yoshikawa, S Handa, M Akaishi, H Mitamura, S Ogawa |
Journal | Cardiology
(Cardiology)
Vol. 86
Issue 3
Pg. 217-23
( 1995)
ISSN: 0008-6312 [Print] Switzerland |
PMID | 7614494
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic beta-Antagonists
- Propanolamines
- Receptors, Adrenergic, beta
- nipradilol
- Metoprolol
|
Topics |
- Adrenergic beta-Antagonists
(therapeutic use)
- Adult
- Aged
- Cardiomyopathy, Dilated
(diagnostic imaging, drug therapy, metabolism)
- Confounding Factors, Epidemiologic
- Coronary Angiography
- Electrocardiography
- Female
- Humans
- Lymphocytes
(drug effects, metabolism)
- Male
- Metoprolol
(therapeutic use)
- Middle Aged
- Propanolamines
(therapeutic use)
- Radionuclide Ventriculography
- Receptors, Adrenergic, beta
(drug effects)
- Ventricular Function, Left
(drug effects)
|